
James R Gorman MD Ph.D.
Principal Investigator, Brain Targeting Program, Wyss Institute/Harvard. Discovering new technologies to transport therapeutics across the blood-brain-barrier into the brain. Pre-competitive sponsored research with multiple pharmaceutical and biotechnology partner companies, and diverse academic collaborators. 25 years experience with Ab drugs, large, medium and startup biopharma companies.
Join to view full profile
3 Blackfan Circle, 222-2Boston, MA 02115
Dr. Gorman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Childrens HospitalInternship, Transitional Year, 1997 - 1998
Harvard Medical School Division of Medical SciencesPhD, Immunology, 1992 - 1997
Harvard Medical SchoolClass of 1997, MD, PhD
Yale UniversityBS, MS, Biology, Summa Cum Laude
Press Mentions
Harvard's Wyss Institute Initiates Industry Partnership to Facilitate Brain-Targeted Drug DeliveryJune 10th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









